Archives
-
Macrophage Vimentin Variant Drives Breast Cancer Migration
2026-09-27
A 2025 preprint reports that tumor-associated macrophages release a caspase-processed vimentin variant that engages IGF-1R on breast cancer cells and promotes migration through RSK and integrin αVβ6. The findings connect immune-cell protein processing to tumor-cell signaling, while the preprint status and available cohort evidence warrant cautious interpretation.
-
IAM-LC vs LEKC for Pulmonary Drug Permeability
2026-09-26
A comparative study of 26 drug-like molecules found that liposome electrokinetic capillary chromatography (LEKC) tracked apparent lung permeability more closely than immobilised artificial membrane liquid chromatography (IAM-LC), while IAM-LC accommodated a broader range of compounds. The findings clarify how membrane-like chromatographic systems can complement conventional partition measurements—and where their predictions need qualification.
-
UBR1 and UBR2 as Mammalian ER Stress Sensors
2026-09-25
The study identifies the N-recognin E3 ligases UBR1 and UBR2 as contributors to mammalian ER stress tolerance: they are normally turned over through K48-linked ubiquitination, become more stable during ER stress, and their loss increases sensitivity to stress-induced apoptosis. The findings extend the protein-quality-control role of the N-degron pathway, while leaving open how UBR1 and UBR2 detect or respond to stress at a molecular level.
-
NU6300 Targets GSDMD Cys191 to Limit Pyroptosis
2026-09-25
The study identifies NU6300 as a covalent gasdermin D (GSDMD) inhibitor that modifies Cys191 and interferes with GSDMD cleavage and palmitoylation. Its results connect this molecular activity to reduced pyroptotic readouts and protection in mouse models, while revealing that effects on upstream inflammasome signaling differ by inflammasome type.
-
Cell lysis buffer for WB and IP in CAF studies
2026-09-24
Connect CAF-driven chemoresistance research to practical Western blot and immunoprecipitation workflows with a non-denaturing lysis buffer. K1123’s defined detergent-and-salt formulation and inhibitor blend support assays that examine signaling proteins and protein associations, while careful controls help distinguish biological effects from extraction artifacts.
-
Viral RIPK3 Degradation Shapes Orthopoxvirus Inflammation
2026-09-24
The study identifies vIRD, an orthopoxvirus factor that recruits host ubiquitin-ligase machinery to promote RIPK3 degradation, suppress necroptosis, and alter infection outcomes. Viral genetics and mouse models connect this mechanism to inflammation and pathogenesis, while also showing how viral gene loss can change host–virus interactions.
-
Lambda Protein Phosphatase for BMAL1 Assay Logic
2026-09-23
Learn how Lambda Protein Phosphatase (λ-PPase) can help test whether BMAL1 phosphorylation contributes to circadian transcription and condensate behavior. This guide focuses on experimental controls, interpretation, and the limits of broad dephosphorylation—not simply enzyme use.
-
MG-262 Proteasome Inhibition Workflows
2026-09-23
MG-262 enables reversible, cell-permeable control of proteasome chymotryptic activity for ubiquitin-proteasome, apoptosis, and cell-cycle experiments. This guide translates pulmonary epithelial signaling findings into practical dose, timing, washout, and troubleshooting strategies while distinguishing established evidence from assay-development recommendations.
-
E-64: From Active-Site Chemistry to In Vivo Insight
2026-09-22
E-64 is an L-trans-epoxysuccinyl peptide that enables irreversible cysteine protease inhibition. This article explains how to interpret its biochemical potency, target engagement, and unexpected in vivo findings without confusing enzyme inhibition with disease modification.
-
Clasto-Lactacystin β-lactone in RIPK3 Assays
2026-09-22
Clasto-Lactacystin β-lactone provides a powerful way to test whether viral RIPK3 loss depends on proteasome activity. This article translates the vIRD findings into a causal assay framework while defining controls, interpretation limits, and practical handling considerations.
-
Ribociclib, Gastric pH, and Acid-Reducing Agents
2026-09-21
This study used an integrated Quality by Design and biorelevant micro-dissolution strategy to examine whether gastric pH elevation could alter ribociclib succinate solubility during concomitant acid-reducing therapy. Although solubility decreased after physiologically relevant pH shifts, the authors concluded that the changes were unlikely to produce a meaningful effect on ribociclib absorption, while demonstrating a practical framework for early pH-mediated interaction assessment.
-
Melatonin Protects Testes from BPA-Induced Damage
2026-09-21
This 2026 Reproductive Toxicology study shows that melatonin mitigates BPA-associated testicular injury in mice by improving antioxidant defenses, mitochondrial dynamics, steroidogenesis, and apoptosis control. Its integrated use of animal toxicology, network pharmacology, mitochondrial assessments, hormone measurements, and tissue analysis provides a mechanistic framework for understanding BPA-related reproductive damage, while also defining important limits for translation beyond mice.
-
AEBSF.HCl: Serine Protease Inhibition Guide
2026-09-20
AEBSF.HCl, also called 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, is an irreversible broad-spectrum serine protease inhibitor for mechanistic research. Product-reported benchmarks cover amyloid precursor protein cleavage, amyloid-beta production, leukemic cell lysis, implantation, solubility, and storage, while peer-reviewed evidence places lysosomal cathepsin activity within necroptosis biology.
-
Leupeptin in Protease-Controlled TET2 Workflows
2026-09-19
Leupeptin combines reversible, competitive inhibition of serine and cysteine proteases with practical utility in lysate protection, autophagy, and antiviral experiments. This guide shows how to use Leupeptin hemisulfate salt without compromising TET2 activity assays, metabolite-binding measurements, or interpretation of protein degradation data.
-
Caspase-3/7 Inhibitor I: Applied Assay Guide
2026-09-18
Caspase-3/7 Inhibitor I provides a reversible, cell-permeable checkpoint for separating executioner-caspase activity from upstream stress, receptor, and mitochondrial signals. This guide translates Candida krusei–induced apoptosis findings into practical co-culture, washout, endpoint, and troubleshooting workflows.